SIA
AMED

Stancorp Investment Advisers’s Amedisys AMED Stock Holding History

Stancorp Investment Advisers’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$2K Hold
67
– – ﹤0.01% 613
2014
Q4 		$2K Buy
+67
New +$1.65K ﹤0.01% 607

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stancorp Investment Advisers's AMED Position: Q1 2015 in Review

Stancorp Investment Advisers held its Amedisys (AMED) position steady in Q1 2015 at 67 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #613.

Stancorp Investment Advisers first reported a position in AMED in Q4 2014 and has held it in 2 quarters since. 133 funds tracked by Wall St. Rank hold AMED as of Q1 2015.

  • Stancorp Investment Advisers held 67 shares of Amedisys worth $2K as of Q1 2015.
  • Stancorp Investment Advisers left its Amedisys share count unchanged in Q1 2015.
  • Amedisys made up ﹤0.01% of Stancorp Investment Advisers's portfolio in Q1 2015, its #613 holding.
  • Stancorp Investment Advisers first reported a position in Amedisys in Q4 2014 and has held it in 2 quarters since.
  • 133 funds tracked by Wall St. Rank held Amedisys as of Q1 2015.

Based on Stancorp Investment Advisers's 13F filing for Q1 2015, filed 13 May 2015.